Seeking Alpha Quant rates LABU as a strong Sell, but I rates it as a Buy due to bullish market conditions. LABU is a leveraged ETF that seeks to track 3x the daily performance of the S&P Biotechnology ...

Although the equities market often embodies chaos and capricious non-linearity, few sectors witness as much kinetic wildness like biotechnology. At its core, biotech represents an innovative push ...

Sean Ross is a strategic adviser at 1031x.com, Investopedia contributor, and the founder and manager of Free Lances Ltd. The Direxion Daily S&P Biotech Bull 3X Fund (NYSEARCA: LABU) is an exchange ...

The Direxion Daily S&P Biotech Bull and Bear 3X Shares (LABU) provides 3x daily exposure to a biotechnology index. Levered ETFs like LABU are designed for short-term trading and may suffer tracking ...

Investors in Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (Symbol: LABU) saw new options become available today, for the June 2nd expiration. At Stock Options ...

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, ...

Direxion Daily S&P Biotech Bull 3X Shares reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period.

Leveraged biotechnology exchange traded funds (ETFs) are known to make big moves, but sometimes those moves are not always about price action. Entering Monday, the Direxion Daily S&P Biotech Bull 3X ...

Not that it went it anywhere, but the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU) has come roaring back with vengeance this month. LABU, the triple-leveraged answer to the SPDR S&P Biotech ...

The Direxion Daily S&P Biotech Bull 3X Fund (NYSEARCA: LABU) is an exchange traded fund (ETF) that seeks to replicate 300% of ...